Addex Therapeutics Ltd (ADXN)

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 71.06K CHF in the quarter ending March 31, 2025, a decrease of -69.75%. This brings the company's revenue in the last twelve months to 246.19K, down -81.76% year-over-year. In the year 2024, Addex Therapeutics had annual revenue of 410.04K, down -74.64%.

• Revenue (ttm): 246.19K CHF
• Revenue Growth: -81.76%
• P/S Ratio: 25.41
• Revenue / Employee: 123,094 CHF
• Employees: 2
• Market Cap: 7.08M USD

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	410.04K	-1.21M	-74.64%
Dec 31, 2023	1.62M	172.23K	11.92%
Dec 31, 2022	1.44M	-1.71M	-54.18%
Dec 31, 2021	3.15M	-725.84K	-18.71%
Dec 31, 2020	3.88M	1.05M	36.89%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.